Shane Barton

Shane Barton is a declared insider at 2 companies (senior executive); the most frequent names are BioAge Labs, Inc. and Precision Biosciences Inc. The record holds 15 filings, for trades running from 26 February 2021 to 30 June 2026.

The open-market side counts 1 purchase for €42k alongside 2 sales. The amount is not disclosed for 2 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant and 11 option exercises. Since January 2026: no purchases and 2 sales on the market.

On 1 July 2026 came the latest disclosure, an option exercise in BioAge Labs, Inc. The clock since the last published purchase (10 March 2025) now reads 587 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.